Photoproduction evidence for and against hidden-strangeness states near 2 GeV

Experimental evidence from coherent diffractive proton scattering has been reported for two narrow baryonic resonances which decay predominantly to strange particles. These states, with masses close to 2.0 GeV would, if confirmed, be candidates for hidden strangeness states with unusual internal structure. In this paper we examine the literature on strangeness photoproduction, to seek additional evidence for or against these states. We find that one state is not confirmed, while for the other state there is some mild supporting evidence favoring its existence. New experiments are called for, and the expected photoproduction lineshapes are calculated.Comment: 9 pages, RevTex, five postscript figures, submitted to PR

Prepare your indicators: Economics imperialism on the shores of law and development

This article explores the influence of economics on the demand for, and deployment of, indicators in the context of the World Bank's investment climate campaign. This campaign is characterised by an emphasis on marketisation, mathematisation and quantification, which are respectively the normative, analytical and empirical approaches of choice in mainstream economics. The article concludes that economics generally, and indicators in particular, have brought a certain discipline and energy to the field of law and development. But this ‘progress’ has often been at the expense of non-economic values and interests, and even of our ability to mourn their loss

Access to Health Care Through Catamount Health; Do Providers Know Enough to Refer?

Background: On November 1, 2007, Vermont launched ‘Catamount Health,’ a state-sponsored private insurance plan. The goal: to close the gap between privately insured and Medicaid insured Vermonters. Previous programs such as Dr. Dynasaur and VHAP were already in place to care for children and low-income residents respectively. Now, under the umbrella title of “Green Mountain Care,” Catamount Health joins them. Catamount Health offers private coverage through either Blue Cross/Blue Shield of VT or MVP Health Care, the cost of which is offset by the state according to income level and household size. To qualify for Catamount, an individual must have an income of at least $1,277 (lower incomes qualify for VHAP), and meet a number of criteria: • Vermont residents 18 years or older • Not currently eligible for other state-sponsored health insurance programs • Have been living without health insurance for 12 months or more unless insurance was lost due to: - Loss of employment - Divorce from or death of a spouse/partner - Dis-enrollment from college or your parent’s plan - No longer eligible for Medicaid or VHAP - No longer have COBRA coverage • Do not have access to insurance through employer The estimate of uninsured Vermonters is 65,000, or 10$1.6 million dollars to fund a large-scale advertising campaign on television, radio, newspaper, and on foot. Following this campaign, there is a high likelihood that Vermonters will bring questions and concerns about Catamount to their physician offices and community leaders, emphasizing the importance of a well-educated provider.https://scholarworks.uvm.edu/comphp_gallery/1021/thumbnail.jp

Obtaining sigma --> gamma gamma Width from Nucleon Polarizabilities

We propose a new method that fixes the coupling to two photons of the recently found lightest QCD resonance, the sigma. This coupling provides crucial information for discriminating the yet unknown nature of this special state. Our method uses available data on the nucleon polarizabilities together with analyticity and unitarity. Taking into account all the uncertainties, our result is Gamma_{pole}= 1.2 +- 0.4 keV.Comment: 7 pages, 1 figure, Invited Talk given by J.P. at 14th International Conference on QCD (QCD' 08), 7-12 July 2008, Montpellier, Franc

Paris COP 21: Power that Speaks the Truth?

© 2016 Informa UK Limited, trading as Taylor & Francis Group In this paper, I set out some of the key aspects of the Paris COP 21 Climate Change Agreement. The Paris Agreement was initially reported as a major success. However, this was in so far as many thought any kind of agreement at all was unlikely, and because the Agreement includes Article 2: an aspiration to maintain average global temperature increases to significantly less than 2°C. I then ask the question: if the Paris Agreement is a success of sorts, has anything fundamental changed in order to translate the conditional success of achieving an agreement into an actual success that will realise the goals of the Agreement? I address this in terms of early assessment of trends and the Nationally Determined Contributions, how responsibility is positioned in the Agreement, and the political economy context, which has called forth the need for an agreement

f0(980) meson as a K bar K molecule in a phenomenological Lagrangian approach

We discuss a possible interpretation of the f0(980) meson as a hadronic molecule - a bound state of K and bar K mesons. Using a phenomenological Lagrangian approach we calculate the strong f0(980) to pi pi and electromagnetic f0(980) to gamma gamma decays. The compositeness condition provides a self-consistent method to determine the coupling constant between f0 and its constituents, K and bar K. Form factors governing the decays of the f0(980) are calculated by evaluating the kaon loop integrals. The predicted f0(980) to pi pi and f0(980) to gamma gamma decay widths are in good agreement with available data and results of other theoretical approaches.Comment: 21 pages, 11 figures, revised version accepted for publication in Eur. Phys. J.

The Vehicle, Spring 2007

Table of Contents She Might Just Take You for GrantedRebecca M. Griffithpage 1 ShwagDarius Juttipage 2 In LoveAmanda Vealepage 9 SubmissiveSarah Ellerpage 10 Wedding SongRebecca M. Griffithpage 11 Why No Ladies and Gentlemen, My Shit Never StinksJacob Fosterpage 13 Death of an English MajorLindsey Durbinpage 14 Summer\u27s PerfumeRebecca M. Griffithpage 15 Gigavolt and ChrisEric Schumacherpage 16 UntitledKris Jonespage 22 Ode to the MuseGreg Harrellpage 23 TenderAmanda Vealepage 24 When the Muses HeaveElizabeth Hoodpage 25 Depression LiftingAmanda Vealepage 26 Red SwordAndrew Deckerpage 27 Warring IdeologyMargaret B. Hamperpage 29 ConfessionGreg Harrellpage 34 A Glass PuzzleBrittany Morganpage 35 Hey MaJacob Fosterpage 36 As July Faded AwayRebecca M. Griffithpage 37 About the LeftoversGina LoBiancopage 38 Me, Myself & ILindsey Durbinpage 39 Iced Parking LotRebecca M. Griffithpage 41 About the Authors Art Submissions Mike\u27s Revelation and MikeSean Walkercovers UntitledChad Navelpage 9 Morning in Tintern AbbeyCarrie Muellerpage 12 WestminsterCarrie Muellerpage 21 A Fighting ChanceOsha Rudduckpage 22 Rooftop SunsetJennifer O\u27Neilpage 25 EIU IVCarrie Muellerpage 28 MandolinOsha Rudduckpage 38 EIU IIICarrie Muellerpage 42https://thekeep.eiu.edu/vehicle/1087/thumbnail.jp

Transcranial direct current stimulation in the treatment of visual hallucinations in Charles Bonnet syndrome: A randomized placebo-controlled crossover trial.

Objective To investigate the potential therapeutic benefits and tolerability of inhibitory transcranial direct current stimulation (tDCS) on the remediation of visual hallucinations in Charles Bonnet Syndrome (CBS). Design Randomized, double-masked(blind), placebo-controlled crossover trial. Participants Sixteen individuals diagnosed with CBS secondary to visual impairment caused by eye disease experiencing recurrent visual hallucinations. Intervention All participants received four consecutive days of active and placebo cathodal stimulation (current density: 0.29mA/cm2) to the visual cortex (Oz) over two defined treatment weeks, separated by a four-week wash-out period. Main Outcome Measures Ratings of visual hallucination frequency and duration following active and placebo stimulation, accounting for treatment order, using a 2x2 repeated measures model. Secondary outcomes included impact ratings of visual hallucinations and electrophysiological measures. Results When compared to placebo treatment, active inhibitory stimulation of visual cortex resulted in a significant reduction in the frequency of visual hallucinations measured by the North East Visual Hallucinations Interview, with a moderate-to-large effect size. Impact measures of visual hallucinations improved in both placebo and active conditions suggesting support and education for CBS may have therapeutic benefits. Participants who demonstrated greater occipital excitability on electroencephalography assessment at the start of treatment were more likely to report a positive treatment response. Stimulation was found to be tolerable in all participants with no significant adverse effects reported, including no deterioration in pre-existing visual impairment. Conclusions Findings indicate that inhibitory tDCS of visual cortex may reduce the frequency of visual hallucinations in people with CBS, particularly individuals who demonstrate greater occipital excitability prior to stimulation. tDCS may offer a feasible, novel intervention option for CBS with no significant side effects, warranting larger scale clinical trials to further characterize its efficacy

Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression

Associations between single nucleotide polymorphisms (SNPs) at 5p15 and multiple cancer types have been reported. We have previously shown evidence for a strong association between prostate cancer (PrCa) risk and rs2242652 at 5p15, intronic in the telomerase reverse transcriptase (TERT) gene that encodes TERT. To comprehensively evaluate the association between genetic variation across this region and PrCa, we performed a fine-mapping analysis by genotyping 134 SNPs using a custom Illumina iSelect array or Sequenom MassArray iPlex, followed by imputation of 1094 SNPs in 22 301 PrCa cases and 22 320 controls in The PRACTICAL consortium. Multiple stepwise logistic regression analysis identified four signals in the promoter or intronic regions of TERT that independently associated with PrCa risk. Gene expression analysis of normal prostate tissue showed evidence that SNPs within one of these regions also associated with TERT expression, providing a potential mechanism for predisposition to disease

Investigation of structural brain changes in Charles Bonnet Syndrome

Background and objectives In Charles Bonnet Syndrome (CBS), visual hallucinations (VH) are experienced by people with sight loss due to eye disease or lesional damage to early visual pathways. The aim of this cross-sectional study was to investigate structural brain changes using magnetic resonance imaging (MRI) in CBS. Methods Sixteen CBS patients, 17 with eye disease but no VH, and 19 normally sighted people took part. Participants were imaged on a 3T scanner, with 1 mm resolution T1 weighted structural imaging, and diffusion tensor imaging with 64 diffusion directions. Results The three groups were well matched for age, sex and cognitive scores (MMSE). The two eye disease groups were matched on visual acuity. Compared to the sighted controls, we found reduced grey matter in the occipital cortex in both eye disease groups. We also found reductions of fractional anisotropy and increased diffusivity in widespread areas, including occipital tracts, the corpus callosum, and the anterior thalamic radiation. We did not find any significant differences between the eye disease participants with VH versus without VH, but did observe a negative association between hippocampal volume and VH severity in the CBS group. Discussion Our findings suggest that although there are cortical and subcortical effects associated with sight loss, structural changes do not explain the occurrence of VHs. CBS may relate instead to connectivity or excitability changes in brain networks linked to vision